Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Malignancies in children and young adults on etanercept: summary of cases from clinical trials and post marketing reports.

Hooper M, Wenkert D, Bitman B, Dias VC, Bartley Y.

Pediatr Rheumatol Online J. 2013 Oct 2;11(1):35. doi: 10.1186/1546-0096-11-35.

2.

Summary of worldwide pediatric malignancies reported after exposure to etanercept.

McCroskery P, Wallace CA, Lovell DJ, Stryker S, Chernyukhin N, Blosch C, Zack DJ.

Pediatr Rheumatol Online J. 2010 Jun 14;8:18. doi: 10.1186/1546-0096-8-18.

3.

Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration.

Diak P, Siegel J, La Grenade L, Choi L, Lemery S, McMahon A.

Arthritis Rheum. 2010 Aug;62(8):2517-24. doi: 10.1002/art.27511.

4.

[Malignancy and tumor necrosis factor inhibitors in juvenile idiopathic arthritis].

Horneff G.

Z Rheumatol. 2010 Aug;69(6):516-26. doi: 10.1007/s00393-010-0655-8. Review. German.

PMID:
20532787
5.

Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohort.

Silva F, Seo P, Schroeder DR, Stone JH, Merkel PA, Hoffman GS, Spiera R, Sebastian JK, Davis JC Jr, St Clair EW, Allen NB, McCune WJ, Ytterberg SR, Specks U; Wegener's Granulomatosis Etanercept Trial Research Group..

Arthritis Rheum. 2011 Aug;63(8):2495-503. doi: 10.1002/art.30394.

6.

Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents.

Nordstrom BL, Mines D, Gu Y, Mercaldi C, Aquino P, Harrison MJ.

Arthritis Care Res (Hoboken). 2012 Sep;64(9):1357-64. doi: 10.1002/acr.21709.

7.

Childhood cancer among Alaska Natives.

Lanier AP, Holck P, Ehrsam Day G, Key C.

Pediatrics. 2003 Nov;112(5):e396.

PMID:
14595083
8.

Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.

Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.

Arch Dermatol. 2007 Jan;143(1):45-50.

PMID:
17224541
9.

Update on malignancies in children with juvenile idiopathic arthritis in the German BIKER Registry.

Horneff G, Klein A, Oommen PT, Hospach A, Foeldvari I, Feddersen I, Minden K.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1113-1120. Epub 2016 Sep 8.

PMID:
27749226
10.
11.

Italian cancer figures, report 2012: Cancer in children and adolescents.

AIRTUM Working Group.; CCM.; AIEOP Working Group..

Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. English, Italian.

12.

A multi-institutional study of malignancies after heart transplantation and a comparison with the general United States population.

Higgins RS, Brown RN, Chang PP, Starling RC, Ewald GA, Tallaj JA, Kirklin JK, George JF.

J Heart Lung Transplant. 2014 May;33(5):478-85. doi: 10.1016/j.healun.2014.01.862. Epub 2014 Jan 28.

PMID:
24630406
13.

Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population.

Schabert VF, Watson C, Joseph GJ, Iversen P, Burudpakdee C, Harrison DJ.

J Manag Care Pharm. 2013 Oct;19(8):621-30.

14.

Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.

Shah BK, Khanal A.

Anticancer Res. 2015 Jun;35(6):3437-40.

PMID:
26026107
15.

Do tumor necrosis factor inhibitors increase cancer risk in patients with chronic immune-mediated inflammatory disorders?

Chen Y, Friedman M, Liu G, Deodhar A, Chu CQ.

Cytokine. 2016 Sep 26. pii: S1043-4666(16)30519-1. doi: 10.1016/j.cyto.2016.09.013. [Epub ahead of print]

PMID:
27688201
16.

TNF-alpha inhibitors for ankylosing spondylitis.

Maxwell LJ, Zochling J, Boonen A, Singh JA, Veras MM, Tanjong Ghogomu E, Benkhalti Jandu M, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2015 Apr 18;(4):CD005468. doi: 10.1002/14651858.CD005468.pub2. Review.

PMID:
25887212
17.

Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.

Brewer JD, Shanafelt TD, Call TG, Cerhan JR, Roenigk RK, Weaver AL, Otley CC.

Int J Dermatol. 2015 Aug;54(8):e287-93. doi: 10.1111/ijd.12564. Epub 2015 Mar 13.

PMID:
25772131
18.

No evidence for increased risk of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis receiving etanercept for up to 5 years.

Lebwohl M, Blum R, Berkowitz E, Kim D, Zitnik R, Osteen C, Wallis WJ.

Arch Dermatol. 2005 Jul;141(7):861-4.

PMID:
16027301
19.

Supplemental Content

Support Center